Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.310
+0.080 (1.89%)
At close: Nov 26, 2025, 4:00 PM EST
4.300
-0.010 (-0.23%)
After-hours: Nov 26, 2025, 4:42 PM EST
Strata Critical Medical Market Cap
Strata Critical Medical has a market cap or net worth of $371.38 million as of November 26, 2025. Its market cap has increased by 24.42% in one year.
Market Cap
371.38M
Enterprise Value
298.93M
1-Year Change
24.42%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since November 5, 2019, Strata Critical Medical's market cap has increased from $335.16M to $371.38M, an increase of 10.81%. That is a compound annual growth rate of 1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 371.38M | 11.58% |
| Dec 31, 2024 | 332.83M | 26.33% |
| Dec 29, 2023 | 263.46M | 2.70% |
| Dec 30, 2022 | 256.52M | -58.82% |
| Dec 31, 2021 | 622.98M | 63.57% |
| Dec 31, 2020 | 380.88M | 12.72% |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 985.91B |
| Johnson & Johnson | 498.84B |
| AbbVie | 409.73B |
| UnitedHealth Group | 295.11B |
| AstraZeneca | 283.06B |
| Merck & Co. | 259.33B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 223.99B |